Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. Through these IDCs, Amerisourcebergen provides a diverse array of essential healthcare commodities, including specialty medications, brand-name and generic drugs, vaccines, medical supplies, and equipment to various federal agencies and healthcare programs. The contracted products and services support the healthcare needs of military personnel, veterans, and other federal beneficiaries across different locations and settings. Amerisourcebergen's federal contracting activities are primarily focused on supplying pharmaceutical and medical supplies to military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company has been awarded numerous delivery orders from the DLA for specific medications and medical supplies, leveraging its extensive supply chain network and expertise in pharmaceutical distribution to efficiently fulfill government requirements. These IDCs enable government agencies to streamline the procurement of essential healthcare materials, ensuring the availability of critical care resources for military, veteran, and other federal healthcare programs.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 5/27/20 |